Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early corticosteroid therapy for COVID-19 pneumonia to prevent progression to severe respiratory failure
2020-002186-34Phase 4Terminated
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jul 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone sodium succinate and methylprednisolone in coronavirus pneumonia (2 arms), sponsored by Vall d'Hebron Research Institute. Started Jul 2020; status: terminated.
02
Drugs
methylprednisolone sodium succinatemethylprednisolone
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on 2020-002186-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002186-34.